Benign thyroid nodules in pediatric patients: The majority of patients with benign thyroid nodules had no significant increase in nodule size in the first year of follow-up, including one patient who was subsequently found to have PTC. We recommend follow-up US at 1 year after initial presentation in low-risk pediatric patients with benign thyroid nodule cytology.

Benign thyroid nodules in pediatric patients: determining best practices for repeat ultrasound evaluations

Juanita K. Hodax

 / Kimberly Bowerman

 / Jose Bernardo Quintos

Published Online: 2019-07-04 | DOI: https://doi.org/10.1515/jpem-2018-0476

30,00 € / $42.00 / £23.00

 GET ACCESS TO FULL TEXT

Abstract

Objective

The American Thyroid Association (ATA) recommendations for the follow-up of thyroid nodules with benign fine needle aspiration (FNA) cytology in children are largely based on adult data, despite well-characterized differences between thyroid nodules in adults and children. We aimed to determine the optimal time interval for repeat evaluation of an FNA-benign thyroid nodule in a pediatric patient.

Methods

This is a retrospective chart review of patients <19 years of age from 2003 to 2013 with a benign thyroid nodule by FNA cytology.

Results

We identified 43 patients with benign thyroid nodule cytology on FNA. The average age at diagnosis was 15.6 years, with female predominance (91%). Initial ultrasound (US) findings showed an average nodule size of 2.5 cm, 10% with calcifications, 37% hyperemia, 29% hypoechogenicity and 7% lymphadenopathy. Follow-up US was done in 42%. The first follow-up US occurred on average at 15 months after the initial US. Four patients had nodules with significant growth over time. One patient with papillary thyroid carcinoma (PTC) on final pathology initially had a decreasing nodule size, and then a subsequent increase in the nodule size after 4.5 years. Thyroid nodules were surgically removed in 33% with the final pathology showing a benign cytology in four patients, follicular adenoma in eight patients and PTC in two patients.

Conclusions

The majority of patients with benign thyroid nodules had no significant increase in nodule size in the first year of follow-up, including one patient who was subsequently found to have PTC. We recommend follow-up US at 1 year after initial presentation in low-risk pediatric patients with benign thyroid nodule cytology.

Keywords: benign thyroid nodule; fine needle aspiration; follicular adenoma; papillary thyroid carcinoma; thyroid nodule

References

• 1.
  Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, et al. 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2016;26:1–133.Web of ScienceCrossrefPubMedGoogle Scholar
• 2.
  Papini E, Guglielmi R, Bianchini A, Crescenzi A, Taccogna S, et al. Risk of malignancy in nonpalpable thyroid nodules: predictive value of ultrasound and color-Doppler features. J Clin Endocrinol Metab 2002;87:1941–6.PubMedCrossrefGoogle Scholar
• 3.
  Carmeci C, Jeffrey RB, McDougall IR, Nowels KW, Weigel RJ. Ultrasound guided fine-needle aspiration biopsy of thyroid masses. Thyroid 1998;8:283–9.PubMedCrossrefGoogle Scholar
• 4.
  Wang CC, Friedman L, Kennedy GC, Wang H, Kebebew E, et al. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. Thyroid 2011;21:243–51.Web of ScienceCrossrefPubMedGoogle Scholar
• 5.
  Francis GL, Waguespack SG, Bauer AJ, Angelos P, Benvenga S, et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2015;25:716–59.Web of ScienceCrossrefPubMedGoogle Scholar
• 6.
  Gupta A, Ly S, Castroneves LA, Frates MC, Benson CB, et al. A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults. J Clin Endocrinol Metab 2013;98:3238–45.CrossrefPubMedWeb of ScienceGoogle Scholar
• 7.
  Niedziela M. Thyroid nodules. Best Pract Res Clin Endocrinol Metab 2014;28:245–77.PubMedCrossrefGoogle Scholar
• 8.
  Mussa A, De Andrea M, Motta M, Mormile A, Palestini N, et al. Predictors of malignancy in children with thyroid nodules. J Pediatr 2015;167:886–92.CrossrefPubMedGoogle Scholar
• 9.
  Yamashita S, Saenko V. Mechanisms of disease: molecular genetics of childhood thyroid cancers. Nat Clin Pract Endocrinol Metab 2007;3:422–9.CrossrefPubMedGoogle Scholar
• 10.
  Rivkees SA, Mazzaferri EL, Verburg FA, Reiners C, Luster M, et al. The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy. Endocr Rev 2011;32:798–826.CrossrefPubMedWeb of ScienceGoogle Scholar
• 11.
  Nou E, Kwong N, Alexander LK, Cibas ES, Marqusee E, et al. Determination of the optimal time interval for repeat evaluation after a benign thyroid nodule aspiration. J Clin Endocrinol Metab 2014;99:510–6.PubMedWeb of ScienceCrossrefGoogle Scholar
• 12.
  Durante C, Costante G, Lucisano G, Bruno R, Meringolo D, et al. The natural history of benign thyroid nodules. J Am Med Assoc 2015;313:926–35.CrossrefGoogle Scholar
• 13.
  Ajmal S, Rapoport S, Ramirez Batlle H, Mazzaglia PJ. The natural history of the benign thyroid nodule: what is the appropriate follow-up strategy? J Am Coll Surg 2015;220:987–92.CrossrefWeb of SciencePubMedGoogle Scholar
• 14.
  Cherella CE, Feldman HA, Hollowell M, Richman DM, Cibas ES, et al. Natural history and outcomes of cytologically benign thyroid nodules in children. J Clin Endocrinol Metab 2018;103:3557–65.CrossrefWeb of SciencePubMedGoogle Scholar
• 15.
  Hodax JK, Reinert SE, Quintos JB. Autonomously functioning thyroid nodules in patients <21 years of age: the Rhode Island Hospital experience from 2003–2013. Endocr Pract 2016;22:328–37.PubMedWeb of ScienceCrossrefGoogle Scholar
• 16.
  Orlandi A, Puscar A, Capriata E, Fideleff H. Repeated fine-needle aspiration of the thyroid in benign nodular thyroid disease: critical evaluation of long-term follow-up. Thyroid 2005;15:274–8.CrossrefPubMedGoogle Scholar
• 17.
  American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Cooper DS, Doherty GM, Haugen BR, Kloos RT, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid 2009;19:1167–214.Web of SciencePubMedCrossrefGoogle Scholar
• 18.
  Lyshchik A, Drozd V, Demidchik Y, Reiners C. Diagnosis of thyroid cancer in children: value of gray-scale and power Doppler US. Radiology 2005;235:604–13.PubMedCrossrefGoogle Scholar
• 19.
  Martinez-Rios C, Daneman A, Bajno L, van der Kaay DC, Moineddin R, et al. Utility of adult-based ultrasound malignancy risk stratifications in pediatric thyroid nodules. Pediatr Radiol 2018;48:74–84.Web of SciencePubMedCrossrefGoogle Scholar
• 20.
  Koltin D, O’Gorman CS, Murphy A, Ngan B, Daneman A, et al. Pediatric thyroid nodules: ultrasonographic characteristics and inter-observer variability in prediction of malignancy. J Pediatr Endocrinol Metab 2016;29:789–94.Web of SciencePubMedGoogle Scholar

About the article

Corresponding author: Jose Bernardo Quintos, MD, Department of Pediatrics, Division of Endocrinology and Diabetes, Hasbro Children’s Hospital, 593 Eddy Street, Providence, RI 02903, USA, Phone: +401-444-5504, Fax: +401-793-8101

aJuanita K. Hodax and Kimberly Bowerman contributed equally to this work.